|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM310603951 |
003 |
DE-627 |
005 |
20231225140443.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2020 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2020.108488
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1035.xml
|
035 |
|
|
|a (DE-627)NLM310603951
|
035 |
|
|
|a (NLM)32479988
|
035 |
|
|
|a (PII)S1521-6616(20)30413-7
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Kolovou, Kyriaki
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a B-cell oligoclonal expansions in renal tissue of patients with immune-mediated glomerular disease
|
264 |
|
1 |
|c 2020
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 01.02.2021
|
500 |
|
|
|a Date Revised 01.02.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2020 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a B-cell clonal expansion has been sporadically described in the blood and/or renal tissue of patients with glomerulonephritides, albeit with unclear pathogenetic role. Herein, using spectratyping analysis, we observed oligoclonal intrarenal B-cell populations in 59% of glomerulonephritis patients with podocyte injury (6/7 with focal segmental glomerulosclerosis, 1/3 minimal change disease, 1/3 idiopathic membranous nephropathy, 3/4 IgA nephropathy, 2/5 membranous lupus nephritis), 20% of glomerulonephritis patients without podocyte involvement (4/13 with mesangial or proliferative lupus nephritis, 0/3 idiopathic membranoproliferative glomerulonephritis, 0/4 pauci-immune vasculitis) and 17% of control patients with renal cancer. In multivariate analysis, oligoclonal B-cells were associated with podocyte injury and the grade of glomerulosclerosis (both p = .009). B-cell oligoclonal expansions were not found in the paired peripheral blood samples. We postulate that B-cell expansion in the kidney results from local stimuli, including antigens expressed on podocytes. Further studies to unravel the role of oligoclonal B-cells in (auto)immune-mediated kidney disease are warranted
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a B-cells
|
650 |
|
4 |
|a Immune-mediated glomerulonephritis
|
650 |
|
4 |
|a Oligoclonal expansion
|
650 |
|
7 |
|a Immunoglobulin Heavy Chains
|2 NLM
|
700 |
1 |
|
|a Laskari, Katerina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Roumelioti, Maria
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tektonidou, Maria G
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Panayiotidis, Panayiotis
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Boletis, John N
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Marinaki, Smaragdi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sfikakis, Petros P
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 217(2020) vom: 30. Aug., Seite 108488
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:217
|g year:2020
|g day:30
|g month:08
|g pages:108488
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2020.108488
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 217
|j 2020
|b 30
|c 08
|h 108488
|